Although mutations in BRCA1 and BRCA2 are two of the most widely known genetic determinants of breast and ovarian cancer, they are among many in a series of CPGs implicated in the formation of hereditary breast cancer (Table 1). This evidence concerns the gene BRCA2 and breast carcinoma.